COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.

Fabricius, Michela M; Dandachi, Dima

Fabricius, Michela M; Dandachi, Dima.

Fabricius MM; Medical Student, University of Missouri-Columbia, Columbia, Missouri.
Dandachi D; Assistant Professor of Clinical Medicine, Medical Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) and Vascular Access, and Medical Director, HIV/AIDS Program, University of Missouri-Columbia, Columbia, Missouri.

Mo Med ; 118(1): 74-80, 2021.

Article in English | MEDLINE | ID: covidwho-1068429

ABSTRACT

ABSTRACT

Convalescent plasma is an old treatment for a new disease. The coronavirus disease 2019 (COVID-19) pandemic caused the analysis of convalescent plasma to reemerge as a possible treatment. First, a systematic review summarizes the available research examining the use of convalescent plasma for the treatment of patients with COVID-19. Second, we describe our experience in establishing a single-center convalescent plasma donation program.

Subject(s)

Blood Donors/supply & distribution; COVID-19/therapy; Immunization, Passive/methods; Adult; Aged; Aged, 80 and over; Blood Donors/statistics & numerical data; COVID-19/diagnosis; COVID-19/epidemiology; COVID-19/virology; Donor Selection/methods; Female; Humans; Male; Middle Aged; SARS-CoV-2/genetics; SARS-CoV-2/isolation & purification; Treatment Outcome; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / Immunization, Passive / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Mo Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google